These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 19207861)

  • 1. Review article: Luminex technology for HLA antibody detection in organ transplantation.
    Tait BD; Hudson F; Cantwell L; Brewin G; Holdsworth R; Bennett G; Jose M
    Nephrology (Carlton); 2009 Apr; 14(2):247-54. PubMed ID: 19207861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid phase assays for HLA antibody detection in clinical transplantation.
    Tait BD
    Curr Opin Immunol; 2009 Oct; 21(5):573-7. PubMed ID: 19765965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid phase HLA antibody detection technology--challenges in interpretation.
    Tait BD; Hudson F; Brewin G; Cantwell L; Holdsworth R
    Tissue Antigens; 2010 Aug; 76(2):87-95. PubMed ID: 20403141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
    Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT
    Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC
    Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.
    Gupta A; Sinnott P
    Hum Immunol; 2009 Aug; 70(8):618-22. PubMed ID: 19374932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant.
    Claas FH; Doxiadis II
    Hum Immunol; 2009 Aug; 70(8):636-9. PubMed ID: 19375467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodologies for anti-HLA antibody screening in patients awaiting kidney transplant: a comparative study.
    Minucci PB; Grimaldi V; Casamassimi A; Cacciatore F; Sommese L; Picascia A; Resse M; Sabia C; Russo A; Napoli C
    Exp Clin Transplant; 2011 Dec; 9(6):381-6. PubMed ID: 22142045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
    Poli F; Cardillo M; Scalamogna M
    Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V; Venetz JP; Pantaleo G; Pascual M
    Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.
    Taylor CJ; Kosmoliaptsis V; Summers DM; Bradley JA
    Hum Immunol; 2009 Aug; 70(8):563-8. PubMed ID: 19445992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.
    Lachmann N; Todorova K; Schulze H; Schönemann C
    Transplantation; 2013 Mar; 95(5):694-700. PubMed ID: 23354296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.